Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
about
How citation distortions create unfounded authority: analysis of a citation networkRole of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathiesGlucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoidsImpaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient miceFunctional imaging in muscular diseasesSimultaneous T₂ and lipid quantitation using IDEAL-CPMG.MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle.Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measuresFormation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositisLaboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups.Mycophenolate mofetil and neurological diseases.Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexateTreatment of inflammatory myopathies.Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositisA case of polymyositis associated with papillary thyroid cancer: a case report.Cytokine Therapies in Neurological Disease.Clinical characteristics and outcomes of juvenile and adult dermatomyositisSkeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patientsReview: An update on inflammatory and autoimmune myopathies.Diagnosis, pathogenesis and treatment of myositis: recent advances.The skeletal muscle arachidonic acid cascade in health and inflammatory disease.Integrated classification of inflammatory myopathies.High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.Immune Mediated Necrotizing Myopathy: a Cause of Isolated Myopathy of Neck Extensor Muscle.Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese population.[The clinical spectrum of dermatomyositis].Annexin expression in inflammatory myopathies.Insulin-like growth factor I in inclusion-body myositis and human muscle cultures.Efficacy and safety of creatine supplementation in juvenile dermatomyositis: A randomized, double-blind, placebo-controlled crossover trial.AIIMDs: An Integrated Framework of Automatic Idiopathic Inflammatory Myopathy Diagnosis for Muscle.Magnetic resonance imaging in the diagnosis of canine inflammatory myopathies in three dogs.
P2860
Q24260685-DAF40A65-E992-44CE-8809-D5A50411DBF5Q26830775-F4460B23-294A-4657-8FFB-5CB3C1E89F5DQ28509978-A2FECB38-29C3-4662-9AB0-396DF2B76F7AQ28511824-CA41687F-C8E5-47DD-9283-42A6128EC56BQ30470355-8B0D0EB4-3FD4-4629-9D00-36F66A40FE41Q33908848-396BF384-998B-4C71-844D-D906731DF76AQ34578181-DA004F32-4C73-457D-93CD-8D448DFEF399Q35094510-0BA538A8-897F-4497-9BD1-52436E92B5B6Q35540694-DC357022-5F2F-46CE-8041-964C13D1DE49Q35704477-F91C999F-96BE-4043-BBFB-53985B0CB8EFQ36041178-F488507B-B526-481F-A6BA-C3837E6E6180Q36085865-ADB37FA6-F84F-4DA8-B970-B2AA4E9C1391Q36142286-07010D7F-A763-4A01-849C-34DB944384D5Q36528220-95FFAEEE-9067-49EC-B72C-C2878887D5AEQ36971146-D5EF9AD1-7062-4FF7-9C51-893B78557C98Q36975362-095BFDAB-64F6-4BD6-9CE2-D44A1A81A474Q37136498-6960503A-A101-4D80-87F4-E0A471794151Q37284770-A4088259-81BC-438B-AEE5-AD0D6C1D9D96Q37293352-1D074534-F367-4623-A980-8405415D0E0FQ37465544-2B4DB855-033C-4027-8A7C-1244B7FA71E2Q37820692-195609E5-1755-4998-9DB0-7997B1802E8DQ38131849-1C343054-A4CF-40F9-9312-142F75943E92Q38182345-253AD140-DC50-4B41-B329-FBE1086300DFQ39027323-0094452C-3CB1-49AA-9DE0-5D7F0CDE8613Q39604919-4A1D6299-49DE-4224-AA1D-725230E9B42BQ42068399-FF4AD15A-D6C5-4781-BE88-D1813B6D79BFQ46709737-DE1BBD19-B782-422C-82E1-131E5822590CQ46864240-EC82A964-D1F9-4D65-9355-AB03D4868DD2Q47279084-50ECE955-9F45-450F-8C83-EC3FA01D467AQ47292492-DF4D44C4-C52E-40CE-812F-EE6DA36C75B7Q48040258-0D1117EF-8CD7-450C-82BE-9F52968626DAQ48573690-11A9BE66-3ACB-4A13-B93D-6402B90A190BQ53509446-473B3EFD-BF6E-4123-974C-4271CDB14118
P2860
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@ast
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@en
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@nl
type
label
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@ast
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@en
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@nl
prefLabel
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@ast
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@en
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@nl
P2093
P2860
P356
P1433
P1476
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
@en
P2093
Beverley A Phillips
Frank L Mastaglia
Michael J Garlepp
Paul J Zilko
P2860
P304
P356
10.1002/MUS.10313
P577
2003-04-01T00:00:00Z